Patents by Inventor Marc Masa Alvarez

Marc Masa Alvarez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9914768
    Abstract: The present invention relates to the use of antibodies against S100A7 protein for the prevention and/or treatment of cancer or a disease associated to an undesired angiogenesis or a disease associated with inflammation; and to methods and kits for diagnosing and determining the prognostic of said diseases in vitro and in vivo by means of detecting levels of S100A7 in a biofluid, preferably with an antibody. The invention also relates to specific anti-S100A7 monoclonal antibodies, hybridoma cell lines producing them and method for obtaining them, as well as pharmaceutical compositions and conjugates containing them.
    Type: Grant
    Filed: April 9, 2014
    Date of Patent: March 13, 2018
    Assignee: Lykera Biomed, S.A.
    Inventors: José Luis Hernández Míguez, Jaume Adan Plana, Josep Maria Martínez Escolà, Marc Masa Álvarez, Ramon Messeguer Peypoch, Francesc Mitjans Prat, Sheila Dakhel Plaza, Antonio Coll Manzano, Rosa Ma Hervas Villegas, Carme Calvis Calpe, Laura Padilla García, Lourdes Tatiana Roque Navarro, Laura Barberà Ferrando, Manuel Rivas Cañas
  • Patent number: 9868784
    Abstract: The present invention relates to the use of antibodies against the S100P protein for the prevention and/or treatment of cancer; and to methods and kits for diagnosing cancer in vitro by means of detecting the levels of S100P in a biofluid, preferably with an antibody. The invention also relates to specific anti-S100P monoclonal antibodies, hybridoma cell lines producing them and method for obtaining them, as well as to pharmaceutical compositions and conjugates containing them.
    Type: Grant
    Filed: December 7, 2015
    Date of Patent: January 16, 2018
    Assignee: LYKERA BIOMED SA
    Inventors: José Luis Hernández Míguez, Jaume Adan Plana, Josep Maria Martínez Escolà, Marc Masa Álvarez, Ramon Messeguer Peypoch, Francesc Mitjans Prat, Sheila Dakhel Plaza, Antonio Coll Manzano, Rosa Ma Hervas Villegas, Carme Calvis Calpe, Laura Padilla García, Lourdes Tatiana Roque Navarro, Laura Barberà Ferrando, Manuel Rivas Cañas
  • Patent number: 9657092
    Abstract: The invention relates to antibodies against S100A4, methods for the preparation of these antibodies, pharmaceutical compositions comprising these antibodies, and therapeutic and diagnostic uses thereof.
    Type: Grant
    Filed: November 25, 2014
    Date of Patent: May 23, 2017
    Inventors: Jose Luis Hernandez Miguez, Jaume Adan Plana, Josep Maria Martinez Escola, Marc Masa Alvarez, Ramon Messeguer Peypoch, Francesc Mitjans Prat, Sheila Dakhel Plaza, Antonio Coll Manzano, Rosa Ma Hervas Villegas, Carme Calvis Calpe, Laura Padilla Garcia, Lourdes Tatiana Roque Navarro, Laura Barbera Ferrando, Manuel Rivas Canas, Luis Angel Gomez Casajus
  • Publication number: 20160090412
    Abstract: The present invention relates to the use of antibodies against the S100P protein for the prevention and/or treatment of cancer; and to methods and kits for diagnosing cancer in vitro by means of detecting the levels of S100P in a biofluid, preferably with an antibody. The invention also relates to specific anti-S100P monoclonal antibodies, hybridoma cell lines producing them and method for obtaining them, as well as to pharmaceutical compositions and conjugates containing them.
    Type: Application
    Filed: December 7, 2015
    Publication date: March 31, 2016
    Inventors: José Luis HERNÁNDEZ MÍGUEZ, Jaume ADAN PLANA, Josep Maria MARTÍNEZ ESCOLÀ, Marc MASA ÁLVAREZ, Ramon MESSEGUER PEYPOCH, Francesc MITJANS PRAT, Sheila DAKHEL PLAZA, Antonio COLL MANZANO, Rosa Mª HERVAS VILLEGAS, Carme CALVIS CALPE, Laura PADILLA GARCÍA, Lourdes Tatiana ROQUE NAVARRO, Laura BARBERÀ FERRANDO, Manuel RIVAS CAÑAS
  • Patent number: 9228011
    Abstract: The present invention relates to the use of antibodies against the S100P protein for the prevention and/or treatment of cancer; and to methods and kits for diagnosing cancer in vitro by means of detecting the levels of S100P in a biofluid, preferably with an antibody. The invention also relates to specific anti-S100P monoclonal antibodies, hybridoma cell lines producing them and method for obtaining them, as well as to pharmaceutical compositions and conjugates containing them.
    Type: Grant
    Filed: January 17, 2012
    Date of Patent: January 5, 2016
    Assignee: Lykera Biomed SA
    Inventors: José Luis Hernández Míguez, Jaume Adan Plana, Josep Maria Martínez Escolà, Marc Masa Álvarez, Ramon Messeguer Peypoch, Francesc Mitjans Prat, Sheila Dakhel Plaza, Antonio Coll Manzano, Rosa Ma Hervas Villegas, Carme Calvis Calpe, Laura Padilla García, Lourdes Tatiana Roque Navarro, Laura Barberà Ferrando, Manuel Rivas Cañas
  • Publication number: 20150079097
    Abstract: The invention relates to antibodies against S100A4, methods for the preparation of these antibodies, pharmaceutical compositions comprising these antibodies, and therapeutic and diagnostic uses thereof.
    Type: Application
    Filed: November 25, 2014
    Publication date: March 19, 2015
    Inventors: Jose Luis Hernandez Miguez, Jaume Adan Plana, Josep Maria Martinez Escola, Marc Masa Alvarez, Ramon Messeguer Peypoch, Francesc Mitjans Prat, Sheila Dakhel Plaza, Antonio Coll Manzano, Rosa Ma Hervas Villegas, Carme Calvis Calpe, Laura Padilla Garcia, Lourdes Tatiana Roque Navarro, Laura Barbera Ferrando, Manuel Rivas Canas, Luis Angel Gomez Casajus
  • Patent number: 8916152
    Abstract: The invention relates to antibodies against S100A4, methods for the preparation of these antibodies, pharmaceutical compositions comprising these antibodies, and therapeutic and diagnostic uses thereof.
    Type: Grant
    Filed: June 14, 2011
    Date of Patent: December 23, 2014
    Assignee: Lykera Biomed SA
    Inventors: Jose Luis Hernandez Miguez, Jaume Adan Plana, Josep Maria Martinez Escola, Marc Masa Alvarez, Ramon Messeguer Peypoch, Francesc Mitjans Prat, Sheila Dakhel Plaza, Antonio Coll Manzano, Rosa Ma Hervas Villegas, Carme Calvis Calpe, Laura Padilla Garcia, Lourdes Tatiana Roque Navarro, Laura Barbera Ferrando, Manuel Rivas Canas, Luis Angel Gomez Casajus
  • Publication number: 20140050734
    Abstract: The present invention relates to the use of antibodies against the S100P protein for the prevention and/or treatment of cancer; and to methods and kits for diagnosing cancer in vitro by means of detecting the levels of S100P in a biofluid, preferably with an antibody. The invention also relates to specific anti-S100P monoclonal antibodies, hybridoma cell lines producing them and method for obtaining them, as well as to pharmaceutical compositions and conjugates containing them.
    Type: Application
    Filed: January 17, 2012
    Publication date: February 20, 2014
    Inventors: José Luis Hernandez Miguez, Jaume Adan Plana, Josep Maria Matìnez Escolà, Marc Masa Álvarez, Ramon Messecuer Peypoch, Francesc Mit Jans Prat, Sheila Dakhel Plaza, Antonio Coll Manzano, Rosa Ma Hervas Billegas, Carme Calvis Calpe, Laura Padilla Garcia, Lourdes Tatiana Toque Navarro, Laura Barberà Ferrando, Manuel Rivas Canas
  • Publication number: 20130101592
    Abstract: The invention relates to antibodies against S100A4, methods for the preparation of these antibodies, pharmaceutical compositions comprising these antibodies, and therapeutic and diagnostic uses thereof.
    Type: Application
    Filed: June 14, 2011
    Publication date: April 25, 2013
    Applicant: LYKERA BIOMED SA
    Inventors: Jose Luis Hernandez Miguez, Jaume Adan Plana, Josep Maria Martinez Escola, Marc Masa Alvarez, Ramon Messeguer Peypoch, Francesc Mitjans Prat, Sheila Dakhel Plaza, Antonio Coll Manzano, Rosa Ma Hervas Villegas, Carme Calvis Calpe, Laura Padilla Garcia, Lourdes Tatiana Roque Navarro, Laura Barbera Ferrando, Manuel Rivas Canas, Luis Angel Gomez Casajus
  • Publication number: 20040241696
    Abstract: The invention provides a method for the genetic analysis of biological samples after generation and expansion of subsets representing their nucleic acids. Each subset contains a characteristic but arbitrarily selected representation. Different subsets display complementary representations. The method is specially suitable for the study of gene expression profiles.
    Type: Application
    Filed: March 8, 2004
    Publication date: December 2, 2004
    Inventors: Miguel A Peinado, Rosa-Ana Risques, Elisenda Vendrell, Gabriel Capella, Monica Grau, Antonia Obrador, Gemma Tarafa, Victor Moreno, Xavier Sole, Elisabet Rosell-Vives, Marta Soler, Marc Masa Alvarez, Jaume Piulats
  • Publication number: 20040137595
    Abstract: MFQ-111 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing MFQ-111 polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: February 19, 2003
    Publication date: July 15, 2004
    Inventors: Marc Masa Alvarez, Blanca Rodes Gubern, Ramon Messeguer Peypoch, Elisabet Rosell Vives, Jaume Piulats Xanco
  • Publication number: 20040073004
    Abstract: MFQ-114 polypeptides and polynucleotides and metnods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing MFQ-114 polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: April 18, 2003
    Publication date: April 15, 2004
    Inventors: Marta Soler Riera, Marc Masa Alvarez, Jose Luis Hernandez Miguez, Jaume Piulats Xanco, Elisabet Rosell Vives